Table 2.
SNP | Funct. | Closest Genes | Chr | Position | A1 | A2 | Freq.A1 | Urate | Gout | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
effect | SE | p-value | OR | 95% CI | p-value | ||||||||
rs2231142 | exonic | ABCG2 | 4 | 89052323 | T | G | 0.11 | 0.40 | 0.05 | 8.8E-14 | 1.54 | 1.34, 1.78 | 5.3E-09 |
rs13111638 | intronic | SLC2A9 | 4 | 9996890 | T | C | 0.19 | −0.31 | 0.04 | 2.0E-13 | 0.77 | 0.68, 0.86 | 2.9E-05 |
SNP indicates the SNP with the lowest p-value for urate; the index SNP at SLC2A9 for gout was rs59834205 (p-value 1.36E-07, LD with rs13111638: r2 = 0.60, D′ = 0.79, using 1000 G phase 3); the index SNP at ABCG2 for gout was rs4148155 (p-value 4.54E-09; LD with rs2231142: r2 = 0.99, D′ = 1, using 1000 G phase 3). Estimates for rs4148155 and rs59834205 are shown in Supplemental Table 2. Abbreviations: Funct., function; Chr, chromosome; A1, coded allele; A2, non-coded allele; Freq.A1, the frequency of the coded allele; effect, effect of A1; SE, standard error; OR, odds ratio; 95% CI, 95% confidence interval. Associations with urate were adjusted for age, sex, log(eGFR), BMI, significant principal components (p < 0.05), intake of diuretics and gout medication, while associations with gout were adjusted for age, sex, log(eGFR), BMI, and intake of diuretics. Associations were filtered for plausibility and quality.